Koers Titan Pharmaceuticals, Inc. OTC Bulletin Board
Aandelen
TTNP
US8883141017
Farmaceutische producten
Omzet 2022 | 557K 514K | Omzet 2023 | 184K 170K | Marktkapitalisatie | 6,21 mln. 5,74 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -10 mln. -9,23 mln. | Nettowinst (verlies) 2023 | -5 mln. -4,62 mln. | EV/omzet 2022 | 15,6 x |
Nettoliquiditeiten 2022 | 2,75 mln. 2,54 mln. | Nettoliquiditeiten 2023 | 6,2 mln. 5,72 mln. | EV/omzet 2023 | 0,11 x |
K/w-verhouding 2022 |
-1,03
x | K/w-verhouding 2023 |
-1,11
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 54,53% |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Avraham Ben-Tzvi
BRD | Director/Board Member | 53 | 15-08-22 |
Gim Shen Seow
CEO | Chief Executive Officer | 42 | 12-10-23 |
Brynner Chiam
BRD | Director/Board Member | - | 12-10-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,74% | 723 mld. | |
+32,22% | 598 mld. | |
-2,07% | 364 mld. | |
+20,25% | 331 mld. | |
+2,99% | 288 mld. | |
+16,60% | 244 mld. | |
+9,77% | 210 mld. | |
-5,15% | 208 mld. | |
+7,43% | 169 mld. |